Sources suggest that the BASF (BAS GY) offer for Evonik (EVK GY) will not be enough, Reuters reports
Newsquawk Staff ·
Sources suggest that the BASF (BAS GY) offer for Evonik (EVK GY) will not be enough, Reuters reports.
What it means
Source-led reports that a bid is insufficient are a standard feature of negotiated and hostile approaches alike, and historically mark the point where the target's camp signals for a higher price rather than where a deal dies. The usual sequence in these episodes is an initial offer below fair value, leakage of dissatisfaction to gauge support, then either a sweetened terms stage or a walkaway, with the target's largest holders and any anchor shareholders the actors whose stance matters most. The distinction worth drawing is whether the shortfall is on headline price or on structure: price gaps tend to close through bumps, while gaps over cash versus stock, governance or break-up concerns are what have historically killed combinations. In German industrials, cross-shareholder attitudes, employee and works-council positions, and the political dimension have shaped outcomes before. Worth watching is whether the bidder's language stays disciplined on valuation, since acquirers that have anchored publicly to price discipline have tended to walk rather than chase, and whether the target's board moves from studied coolness to outright rejection. Until then, the target typically trades as a function of the probability of a bump, while the bidder's shares price the risk of overpayment.
- EUROPEAN OPEN: NVDA higher after results; ENOG LN talks for BP/ LN Egypt assets stall; GSK LN Nelkarmi wins accelerated FDA approval; Brazil challenges EU review of AAL LN nickel sale; ALO FP posts H1 loss, launches debt plan
- European Movers: Siemens Energy (ENR GY) +2.9%, ASML (ASML NA) +2.6%, ASM International (ASM NA) +2.5%, Alstom (ALO FP) -7.4%, Anglo American (AAL LN) -2.8%, BP (BP/ LN) -0.7%
- Newsquawk Daily European Equity Opening News - 18th November 2026
- European Closes: Euro Stoxx 50 -2.04% at 6,219, Dax 40 -1.97% at 26,076, FTSE 100 -1.76% at 10,690, CAC 40 -1.62% at 8,217, FTSE MIB -1.31% at 50,846, IBEX 35 -1.61% at 19,625, PSI -1.20% at 9,594, SMI -1.43% at 14,976, AEX -2.14% at 1,110
- BASF (BAS GY) is reportedly preparing an improved offer for Evonik (EVK GY), Bloomberg reports
Related headlines
- Daily US Equity Opening News: US moves ahead on Chinese data centre equipment restrictions; JPM CFO transition19 hours ago
- ALK-Abello (ALKB DC) Q3 2026 (DKK): Revenue 1.76bln (exp. 1.76bln). Confirms FY26 guidance20 hours ago
- German Finance Minister, on the Deutsche Bank (DBK GY) leaks, says the reports show the fight against money laundering and other criminal activity must be pursued with determination20 hours ago
- Telenor Norway (TEL NO) CEO is to step down, Knut Giske has been appointed as acting CEO21 hours ago
- Daily US Equity Opening News - NVDA says US rules could spark legal action; ANT IPO could drive USD 19bln index demand; AAPL & SSNLF near DRAM supply deal; AAPL faces Paris trial over repairs; DASH & CART face DoJ antitrust; CVX near USD 5bln Beacon deal23 hours ago
- European Movers: Deutsche Bank (DBK GY) -5%, Moncler (MONC IM) -2.2%, SAP (SAP GY) -2%, Dassault Systemes (DSY FP) +0.5%1 day ago
- EUROPEAN OPEN: DSY FP targets double-digit growth by 2029; ROP SW's Wilserdly & NOVN SW's Cosentyx win FDA approval; AVIO IM gets EUR 2.05bln Iceye offer; IMB LN plans 2,000+ more job cuts, announces GBP 1.5bln buyback; CVC NA abandons IRCA acquisition1 day ago
- European Pre-Market Summary - 17th November 2026: Weakness in Asia set to feed into Europe as markets prepare for Nvidia (NVDA) earnings1 day ago
- Additional European Equity News - 17th November 20261 day ago
- Newsquawk Daily European Equity Opening News - 17th November 20261 day ago
- European Closes: Euro Stoxx 50 -0.60% at 6,348, Dax 40 -0.45% at 26,630, FTSE 100 -0.09% at 10,893, CAC 40 -0.20% at 8,352, FTSE MIB -0.65% at 51,521, IBEX 35 -0.37% at 19,947, PSI +0.13% at 9,710, SMI +0.55% at 15,189, AEX -0.60% at 1,1341 day ago
- Novo Nordisk (NOVOB DC) says Wegovy resulted in a BMI reduction of 10% or more in almost 80% of children aged 6-121 day ago
- The Bank of Italy is reportedly conducting an inspection into Revolut regarding transparency and consumer protection1 day ago
- Zealand Pharma (ZEAL DC) targets 10 new clinical programmes by 2030 focused on metabolic health, according to remarks at a Jefferies conference1 day ago
- EU antitrust chief Ribera says she would like to see more cross-border bank mergers in the future1 day ago